• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创造免疫赦免:主动的局部抑制,这对“朋友”有益,但却保护了“敌人”。

Creating immune privilege: active local suppression that benefits friends, but protects foes.

作者信息

Mellor Andrew L, Munn David H

机构信息

Immunotherapy and Cancer Centers, Medical College of Georgia, Augusta, Georgia USA.

出版信息

Nat Rev Immunol. 2008 Jan;8(1):74-80. doi: 10.1038/nri2233.

DOI:10.1038/nri2233
PMID:18064049
Abstract

Natural regulatory mechanisms prevent inappropriate immune activation to self and innocuous foreign antigens. Here, we adapt the notion of immune privilege, which was originally applied to transplanted tissues, to consider how antigenic tumour cells and chronic pathogens might exploit natural regulatory mechanisms to become non-immunogenic. This conceptual approach reveals new mechanistic perspectives that may help to explain the paradoxical persistence of tumours and chronic pathogens, and suggests new opportunities to improve immunotherapy to treat these chronic inflammatory diseases.

摘要

天然调节机制可防止对自身和无害外来抗原的不适当免疫激活。在此,我们采用最初应用于移植组织的免疫豁免概念,来探讨抗原性肿瘤细胞和慢性病原体如何利用天然调节机制变得具有非免疫原性。这种概念性方法揭示了新的机制观点,可能有助于解释肿瘤和慢性病原体矛盾的持续存在,并为改善免疫疗法以治疗这些慢性炎症性疾病提供了新的机会。

相似文献

1
Creating immune privilege: active local suppression that benefits friends, but protects foes.创造免疫赦免:主动的局部抑制,这对“朋友”有益,但却保护了“敌人”。
Nat Rev Immunol. 2008 Jan;8(1):74-80. doi: 10.1038/nri2233.
2
TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.Toll样受体(TLR)配体对调节性T细胞(Treg细胞)是抑制还是增强作用?肿瘤免疫中的一把双刃剑。
Oncogene. 2008 Jan 7;27(2):168-80. doi: 10.1038/sj.onc.1210910.
3
Is the liver an important site for the development of immune tolerance to tumours?
Med Hypotheses. 2005;64(4):751-4. doi: 10.1016/j.mehy.2004.10.002.
4
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.T细胞抑制的细胞内在机制及其在癌症治疗中的应用。
Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x.
5
How the immune system achieves self-nonself discrimination during adaptive immunity.在适应性免疫过程中,免疫系统是如何实现自我与非自我识别的。
Adv Immunol. 2009;102:95-133. doi: 10.1016/S0065-2776(09)01202-4.
6
[Immune tolerance and control of CNS autoimmunity: from animal models to MS patients].[免疫耐受与中枢神经系统自身免疫的控制:从动物模型到多发性硬化症患者]
Rev Neurol (Paris). 2007 Sep;163 Spec No 1:3S12-22.
7
Dendritic cells from bench to bedside and back.从实验台到临床再回归:树突状细胞
Immunol Lett. 2009 Feb 21;122(2):128-30. doi: 10.1016/j.imlet.2008.11.017. Epub 2008 Dec 31.
8
Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance.自然杀伤细胞与肺移植:在排斥反应、感染及免疫耐受中的作用
Transpl Immunol. 2008 Apr;19(1):1-11. doi: 10.1016/j.trim.2008.01.004. Epub 2008 Feb 20.
9
Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?我们目前对免疫耐受、自身免疫和免疫抑制机制的理解是否有助于高效癌症疫苗的设计?
Scand J Immunol. 2009 Dec;70(6):516-25. doi: 10.1111/j.1365-3083.2009.02326.x.
10
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.肿瘤诱导的髓源性抑制细胞介导的免疫耐受和免疫抑制
Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x.

引用本文的文献

1
Immune evasion and resistance in breast cancer.乳腺癌中的免疫逃逸与耐药性。
Am J Cancer Res. 2025 Apr 15;15(4):1517-1539. doi: 10.62347/PNGT6996. eCollection 2025.
2
Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy.解析T细胞亚群:洞察其在免疫检查点抑制剂治疗中的作用
Cell Oncol (Dordr). 2025 Apr;48(2):295-312. doi: 10.1007/s13402-024-00992-0. Epub 2024 Sep 26.
3
The multifaceted role of the stroma in the healthy prostate and prostate cancer.基质在健康前列腺和前列腺癌中的多方面作用。
J Transl Med. 2024 Sep 5;22(1):825. doi: 10.1186/s12967-024-05564-2.
4
Variations of VEGFR2 Chemical Space: Stimulator and Inhibitory Peptides.VEGFR2 化学空间的变化:刺激肽和抑制肽。
Int J Mol Sci. 2024 Jul 16;25(14):7787. doi: 10.3390/ijms25147787.
5
Development and Validation of an Immune Prognostic Index Related to Infiltration of CD4+ and CD8+ T Cells in Colorectal Cancer.与结直肠癌中CD4 +和CD8 + T细胞浸润相关的免疫预后指数的开发与验证
Mol Biotechnol. 2024 Jul 18. doi: 10.1007/s12033-024-01237-z.
6
Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy.弥合分歧:揭示癌症与妊娠的共同免疫途径。
Inflamm Res. 2024 May;73(5):793-807. doi: 10.1007/s00011-024-01866-9. Epub 2024 Mar 16.
7
Tumor immunity: A brief overview of tumor‑infiltrating immune cells and research advances into tumor‑infiltrating lymphocytes in gynecological malignancies (Review).肿瘤免疫:肿瘤浸润免疫细胞概述及妇科恶性肿瘤中肿瘤浸润淋巴细胞的研究进展(综述)
Exp Ther Med. 2024 Feb 26;27(4):166. doi: 10.3892/etm.2024.12453. eCollection 2024 Apr.
8
Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.眼部血管疾病:从视网膜免疫特惠到炎症。
Int J Mol Sci. 2023 Jul 28;24(15):12090. doi: 10.3390/ijms241512090.
9
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration.一线转移性胰腺导管腺癌的治疗反应通过肿瘤增殖和 CD8 T 细胞浸润的综合指数进行分层。
Clin Cancer Res. 2023 Sep 1;29(17):3514-3525. doi: 10.1158/1078-0432.CCR-23-0535.
10
Multiple Shades of Gray-Macrophages in Acute Allograft Rejection.急性移植排斥反应中的多种灰色-巨噬细胞。
Int J Mol Sci. 2023 May 4;24(9):8257. doi: 10.3390/ijms24098257.